A1 Life Sciences Inc., in 2019, RTA Laboratories Inc. was established as a subsidiary of A1 Capital with the investment support of A1 Capital. It offers R&D facilities for research projects, cleanroom production facilities for finished products, and a worldwide marketing network for ready-to-sell products.
It proposes a new business model that provides a common platform for potential stakeholders working in the fields listed below and wishing to join the global Biotechnology ecosystem:
1. Raw materials: oligonucleotides, thermostable polymerases, buffer systems.
2. Innovative diagnostic kits, and new diagnostic products.
3. Automated Nucleic Acid Extraction, Real-Time PCR, Thermal Cycler, DNA Sequencing Devices.
4. New Projects in Life Sciences and Diagnosis.
A1 Life Sciences is making rapid progress in its main goal of transforming ideas into products to transport them to end-users in a safe, practical, efficient, and economical way.
